Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Coloplast ASCLPBY -1.32%77 Shiller PE Ratio is 20.33 as of Aug. 04, 2026, which is 61% below its 10-year median of 51.66. GuruFocus rates CLPBY with a GF Score™ of 77/100 and a GF Value™ of $13.05 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 310 Medical Devices & Instruments companies, Coloplast AS ranks better than 61.29% on this metric.
As of today (2026-08-04), Coloplast AS's current share price is $6.71. Coloplast AS's E10 for the quarter that ended in Mar. 2026 was $0.33. Coloplast AS's Shiller PE Ratio for today is 20.33.
The historical rank and industry rank for Coloplast AS's Shiller PE Ratio or its related term are showing as below:
CLPBY'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 17.98 Med: 51.66 Max: 84.59
Current: 20.97
During the past years, Coloplast AS's highest Shiller PE Ratio was 84.59. The lowest was 17.98. And the median was 51.66.
CLPBY's Shiller PE Ratio is ranked better than 61.29% of 310
companies
in the Medical Devices & Instruments industry
Industry Median: 25.975
vs CLPBY: 20.97
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Coloplast AS's adjusted earnings per share data for the three months ended in Mar. 2026 was $-0.067. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $0.33 for the trailing ten years ended in Mar. 2026.
Shiller PE for Stocks: The True Measure of Stock Valuation
Coloplast AS (OTCPK:CLPBY) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Coloplast AS Shiller PE Ratio Related Terms
Coloplast AS Shiller PE Ratio Historical Data
* Premium members only.
The historical data trend for Coloplast AS's Shiller PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLPBY vs ISRG, BDX, MDLN: Shiller PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Coloplast AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS Shiller PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Coloplast AS's Shiller PE Ratio falls into.
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
Coloplast AS's Shiller PE Ratio for today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS's E10 for the quarter that ended in Mar. 2026 is calculated as:
For example, Coloplast AS's adjusted earnings per share data for the three months ended in Mar. 2026 was:
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Coloplast AS (CLPBY) has a Shiller PE Ratio of 20.33 as of Aug. 04, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Coloplast AS and its competitors. This is 61% below median its historical median of 51.66. Over the past decade, Coloplast AS's Shiller PE Ratio has ranged from 17.98 to 84.59. According to the industry distribution chart, Coloplast AS ranks #120 out of 310 companies in the Medical Devices & Instruments industry, placing it in the top 38.7%.
Is Coloplast AS's Shiller PE Ratio too high?
Coloplast AS's current Shiller PE Ratio of 20.33 is 61% below median its 10-year median of 51.66. Over the past 10 years, this metric has ranged from a low of 17.98 to a high of 84.59. The Medical Devices & Instruments industry median Shiller PE Ratio is 25.98. Coloplast AS's value of 20.33 is 21.7% below this industry median. Based on the distribution chart, Coloplast AS ranks #120 out of 310 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Coloplast AS has a GF Score™ of 77/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Shiller PE Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #120 out of 310 companies for Shiller PE Ratio. This puts Coloplast AS in the upper half of its industry. The industry median Shiller PE Ratio is 25.98. Coloplast AS's value of 20.33 is 21.7% below this benchmark. Historically, Coloplast AS's own Shiller PE Ratio has ranged from 17.98 to 84.59 over the past decade. While the company's 10-year median is 51.66 vs. the industry median of 25.98, Coloplast AS has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Devices & Instruments company?
The median Shiller PE Ratio among Medical Devices & Instruments companies is 25.98, based on 310 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coloplast AS's current Shiller PE Ratio of 20.33 is 21.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median Shiller PE Ratio is 25.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current Shiller PE Ratio is 20.33, which is 61% below median its own 10-year median of 51.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBY) is currently considered Significantly Undervalued. The stock's GF Value™ is $13.05, compared to a current price of $6.71 — trading 48.6% below its estimated fair value. The current Shiller PE Ratio is 20.33, which is 61% below median its 10-year median of 51.66 and 21.7% below the Medical Devices & Instruments industry median of 25.98. Coloplast AS's overall GF Score™ is 77/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Coloplast AS (CLPBY), the current Shiller PE Ratio is 20.33 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBY) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $6.71 is trading 48.6% below its estimated GF Value™ of $13.05.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBY:
Shiller PE Ratio: 20.33 (61% below median its 10-year median of 51.66)
GF Value™: $13.05 vs. price of $6.71 (48.6% below fair value)
Industry Position: 21.7% below the Medical Devices & Instruments median (#120 of 310)
No single metric tells the full story. See the CLPBY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
77GF Score
Get the complete analysis for CLPBY
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBY has been successfully added to your 
